Macter International Limited
Dr. Jibran Khan, R. Ph., PhD has a diverse and extensive work experience in the field of regulatory affairs. Dr. has held various positions in multiple pharmaceutical companies, demonstrating their expertise in ensuring compliance with global government regulatory bodies and managing domestic and global regulatory activities. Dr. Khan has served as Head of Regulatory Affairs and Group Manager Regulatory Affairs, where they developed strategies, led teams, and oversaw the approval of marketing authorization. Additionally, they have worked as a Regulatory Affairs and Business Development Consultant, providing services such as dossier preparation, regulatory intelligence gathering, and product registration. Dr. Khan's experience also includes roles in regulatory compliance, qualification and validation, and interning at GlaxoSmithKline. Through their roles, they have demonstrated strong leadership skills, excellent interpersonal abilities, and a commitment to maintaining current knowledge of regulations applicable to the industry.
Dr. Jibran Khan, R. Ph., PhD has a diverse education history. Dr. obtained a Business Communication Skills Course from the Institute of Business Administration in 2013. In 2013, they also earned a Doctor of Pharmacy (PharmD) degree from the University of Sindh. Additionally, they completed a Clinical Research Associate Training Program at Norton Audits, Inc in 2012. Prior to that, they obtained a Master in Pharmaceutical Sciences degree from the University of Karachi in 2009 and a Bachelor in Pharmaceutical Sciences degree from the University of Sindh in 2006. Dr. Khan also holds additional certifications related to pharmaceutical sciences, administration, and regulatory affairs from various institutions such as the FDA and the World Health Organization.
Macter International Limited
3 followers
Macter is amongst the leading Pharmaceutical companies in Pakistan. Macter is a public limited Co. and has a successful 30 years track record in the manufacturing of pharma formulations. The principal activity of the Co. is to manufacture and market pharmaceutical products. The Co. enjoys a sterling reputation of quality and is amongst the top 5 manufacturers by volume. Macter has strong corporate governance structure and systems. In view of Macter’s capabilities and growth prospects, International FI’s have recently invested into the Co. As a company, our first responsibility is to our customers – the doctor who prescribes our product and the patient who uses them. To meet their needs satisfactorily on a long-term horizon, quality consciousness and teamwork is ingrained in all our employees at all levels. As an employer, we recognize the individuality of each employee and seek to develop his/her potential, providing fair compensation in a healthy and safe working environment. As a civic-minded institution, we believe in supporting causes that protect our natural surroundings and uplift the health and educational standards of our community. As a firm in a competitive market, we seek to constantly introduce new and innovative products and systems to meet the changing needs of our customers Currently Macter’s business areas are Contract manufacturing and branded generic formulations. Macter is the largest contract manufacturer in Pakistan particularly for the multinational companies with one of the most advanced production facilities offering a wide range of dosage forms: Oral solids and liquids, Parenterals (ampules and vials), Topicals, Metered dose Inhalers, Ear and Eye drops. Dedicated facilities are available for Cephalosporins, Penicillins & Biologics. The manufacturing operations meet international cGMP standards and are quality management system ISO 9001:2008 certified. Macter’s contract manufacturing clients include a number of blue chips multinationals